drugset / Trial / NCT01624077
Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance
NaSingle-groupOpen-labelTreatment
Summary
The first trial will involve the generation of donor alloantigen-specific CD4+CD25+ Tregs from peripheral blood of pre-transplant patients, the administration of the CD4+CD25+ Tregs (1 x 106 cells/kg) at several intervals (for graft specific tolerance induction).
Timeline
- Start
- 2014-12
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regulatory T cells | Cell therapy | 1e+06 cells/kg | — |